Valiant Laborato

Market Cap: Micro Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE0JWS01017
NSEID: VALIANTLAB
BSEID: 543998

INR

94.88

2.93 (3.19%)

BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 15.7 k

Click here to access the older version

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Divi's Lab.

Cipla

Sun Pharma.Inds.

Torrent Pharma

Venus Remedies

Lyka Labs

Zenotech Lab.

Brooks Lab.

Mankind Pharma

Valiant Laborato

Infinium Pharma

Why is Valiant Laboratories Ltd ?

Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 0%

Poor long term growth as Net Sales has grown by an annual rate of -21.00% and Operating profit at -151.01% over the last 5 years
Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -6.14

Flat results in Dec 24

PAT(9M) At Rs -2.90 cr has Grown at -50.10%
NET SALES(HY) At Rs 56.71 cr has Grown at -43.33%
NON-OPERATING INCOME(Q) is 97.53 % of Profit Before Tax (PBT)

Stock is technically in a Mildly Bearish range

Multiple factors for the stock are Bearish like MACD, KST and DOW

Risky - Negative EBITDA

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -43.88%, its profits have fallen by -99%

Underperformed the market in the last 1 year

Even though the market (BSE 500) generated negative returns of -0.93% in the last 1 year, its fall in the stock was much higher with a return of -43.88%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Drugs)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Valiant Laborato for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Valiant Laborato

-43.84%

-1.00

43.71%

SENSEX

0.45%

0.03

14.48%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-21.00%

EBIT Growth (5y)

-151.01%

EBIT to Interest (avg)

-6.14

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

1.08

Tax Ratio

17.53%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

0.00%

ROCE (avg)

4.06%

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.73

EV to EBIT

-26.16

EV to EBITDA

-30.35

EV to Capital Employed

1.74

EV to Sales

3.73

PEG Ratio

Dividend Yield

ROCE (Latest)

-9.66%

ROE (Latest)

-4.31%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bullish

Bearish

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

9What is working for the Company

PAT(Q)

At Rs 2.35 cr has Grown at 194.1% (vs previous 4Q average

NET SALES(Q)

At Rs 35.23 cr has Grown at 26.4% (vs previous 4Q average

PBDIT(Q)

Highest at Rs 0.62 cr.

OPERATING PROFIT TO NET SALES(Q)

Highest at 1.76%

PBT LESS OI(Q)

Highest at Rs 0.04 cr.

EPS(Q)

Highest at Rs 0.54

-11What is not working for the Company

PAT(9M)

At Rs -2.90 cr has Grown at -50.10%

NET SALES(HY)

At Rs 56.71 cr has Grown at -43.33%

NON-OPERATING INCOME(Q)

is 97.53 % of Profit Before Tax (PBT

Loading Valuation Snapshot...

Here's what is working for Valiant Laborato

Profit After Tax (PAT) - Quarterly

At Rs 2.35 cr has Grown at 194.1% (vs previous 4Q average)

over average PAT of the previous four quarters of Rs -2.50 Cr

MOJO Watch

Near term PAT trend is very positive

PAT (Rs Cr)

Net Sales - Quarterly

At Rs 35.23 cr has Grown at 26.4% (vs previous 4Q average)

over average Net Sales of the previous four quarters of Rs 27.87 Cr

MOJO Watch

Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly

Highest at Rs 0.62 cr.

in the last five quarters

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly

Highest at 1.76%

in the last five quarters

MOJO Watch

Company's efficiency has improved

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly

Highest at Rs 0.04 cr.

in the last five quarters

MOJO Watch

Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly

Highest at Rs 2.35 cr.

in the last five quarters

MOJO Watch

Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly

Highest at Rs 0.54

in the last five quarters

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)

Here's what is not working for Valiant Laborato

Non Operating Income - Quarterly

is 97.53 % of Profit Before Tax (PBT)

MOJO Watch

The company's income from non business activities is high; which is not a sustainable business model

Non Operating Income to PBT